The curious case of human gene patents

The following is an excerpt.

Critics who think the U.S. Patent Office has been too liberal in awarding protection for naturally occurring phenomena like human genes are watching Association for Molecular Pathology v. Myriad Genetics closely for signs the U.S. Supreme Court will tighten controls in this area. It’s an easy position to sympathize with; how can someone own the rights to a human gene?

But Myriad raises tough questions, including what happens to the 100,000 or so genetic patents already awarded.

Read the full story: The Curious Case of Human Gene Patents

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend